Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Pentokey Organy (India)'s 5-Year Yield-on-Cost % or its related term are showing as below:
BOM:524210's 5-Year Yield-on-Cost % is not ranked *
in the Chemicals industry.
Industry Median: 1.82 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Pentokey Organy (India) 5-Year Yield-on-Cost % Related Terms
BOM:524210 vs DOW: 5-Year Yield-on-Cost % Comparison
For the Chemicals subindustry, Pentokey Organy (India)'s 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pentokey Organy (India) 5-Year Yield-on-Cost % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Pentokey Organy (India)'s 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Pentokey Organy (India)'s 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Pentokey Organy (India) (BOM:524210) has a 5-Year Yield-on-Cost % of 0.00 as of Sep. 17, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Pentokey Organy (India) and its competitors. According to the industry distribution chart, Pentokey Organy (India) ranks #999999 out of 1029 companies in the Chemicals industry.
Is Pentokey Organy (India)'s 5-Year Yield-on-Cost % too high?
Pentokey Organy (India)'s current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Pentokey Organy (India) ranks #999999 out of 1029 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Pentokey Organy (India) has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pentokey Organy (India)'s 5-Year Yield-on-Cost % compare to DOW?
According to the Chemicals industry distribution chart, Pentokey Organy (India) ranks #999999 out of 1029 companies for 5-Year Yield-on-Cost %. This places Pentokey Organy (India) in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 1.82. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Chemicals company?
The median 5-Year Yield-on-Cost % among Chemicals companies is 1.82, based on 1,029 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Pentokey Organy (India) and its competitors. For the Chemicals industry, the median 5-Year Yield-on-Cost % is 1.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pentokey Organy (India)'s current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pentokey Organy (India) stock overvalued right now?
Based on GuruFocus' analysis, Pentokey Organy (India) (BOM:524210) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹25.52, compared to a current price of ₹35.99 — trading 41% above its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Pentokey Organy (India)'s overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Pentokey Organy (India) (BOM:524210), the current 5-Year Yield-on-Cost % is 0.00 as of Sep. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pentokey Organy (India) (BOM:524210) Overvalued in 2026?
Based on GuruFocus' analysis, Pentokey Organy (India) stock appears to be overvalued.
The current stock price of ₹35.99 is trading 41% above its estimated GF Value™ of ₹25.52.
GuruFocus considers Pentokey Organy (India) to be Significantly Overvalued.
Key valuation signals for BOM:524210:
5-Year Yield-on-Cost %: 0.00
GF Value™: ₹25.52 vs. price of ₹35.99 (41% above fair value)
No single metric tells the full story. See the BOM:524210 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pentokey Organy (India) Ltd is engaged in the trading of Pharmaceutical Goods. It manufactures various chemical products such as Acetic acid, Ethyl acetate, and Acetaldehyde and Butyl acetate. These products are used for various purposes including textile processing, pharmaceuticals, pesticides, printing inks, paints, and coatings, perfumes, polyester resins and basic dyes, solvents and many more. The only segment in which the Company engaged in the Trading of Pharmaceutical Products.
50GF Score
Get the complete analysis for BOM:524210
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524210 has been successfully added to your 
